DELIVER Trademark

Trademark Overview

On Friday, November 5, 2021, a trademark application was filed for DELIVER with the United States Patent and Trademark Office. The USPTO has given the DELIVER trademark a serial number of 97110247. The federal status of this trademark filing is FIFTH EXTENSION - GRANTED as of Monday, September 29, 2025. This trademark is owned by DELIVER Therapeutics, Inc. The DELIVER trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical products for the prevention and treatment of cancer and aging
deliver

General Information

Serial Number97110247
Word MarkDELIVER
Filing DateFriday, November 5, 2021
Status734 - FIFTH EXTENSION - GRANTED
Status DateMonday, September 29, 2025
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, September 20, 2022

Trademark Statements

Goods and ServicesPharmaceutical products for the prevention and treatment of cancer and aging

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateMonday, November 15, 2021
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameDELIVER Therapeutics, Inc
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressSurfside, FL 33154
Party NameDELIVER Therapeutics, Inc
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressSurfside, FL 33154

Trademark Events

Event DateEvent Description
Tuesday, November 9, 2021NEW APPLICATION ENTERED
Monday, November 15, 2021NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Monday, May 15, 2023SOU EXTENSION 1 FILED
Tuesday, August 16, 2022ASSIGNED TO EXAMINER
Tuesday, August 16, 2022APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, August 31, 2022NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, September 20, 2022PUBLISHED FOR OPPOSITION
Tuesday, September 20, 2022OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, November 15, 2022NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Monday, May 15, 2023SOU TEAS EXTENSION RECEIVED
Monday, May 15, 2023SOU EXTENSION 1 GRANTED
Wednesday, May 17, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, November 15, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, May 14, 2024SOU TEAS EXTENSION RECEIVED
Wednesday, May 15, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, November 13, 2023SOU TEAS EXTENSION RECEIVED
Monday, November 13, 2023SOU EXTENSION 2 FILED
Monday, November 13, 2023SOU EXTENSION 2 GRANTED
Tuesday, May 14, 2024SOU EXTENSION 3 FILED
Tuesday, May 14, 2024SOU EXTENSION 3 GRANTED
Monday, November 11, 2024SOU TEAS EXTENSION RECEIVED
Monday, November 11, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, November 11, 2024SOU EXTENSION 4 GRANTED
Sunday, May 11, 2025SOU EXTENSION 5 FILED
Monday, September 29, 2025SOU EXTENSION 5 GRANTED
Monday, September 29, 2025CASE ASSIGNED TO INTENT TO USE PARALEGAL
Tuesday, September 30, 2025NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, November 11, 2024SOU EXTENSION 4 FILED
Monday, May 12, 2025SOU TEAS EXTENSION RECEIVED

Related Keywords

deliver cancer aging treatment prevention products pharmaceutical